FRANCESCHI, MARIA CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.269
AS - Asia 795
EU - Europa 624
SA - Sud America 76
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 2.797
Nazione #
US - Stati Uniti d'America 1.254
CN - Cina 412
SG - Singapore 264
IE - Irlanda 214
SE - Svezia 206
BR - Brasile 69
TR - Turchia 66
NL - Olanda 46
DE - Germania 36
FI - Finlandia 34
CI - Costa d'Avorio 20
RU - Federazione Russa 18
IT - Italia 17
GB - Regno Unito 16
IN - India 12
CA - Canada 11
IR - Iran 7
RO - Romania 7
HK - Hong Kong 6
IL - Israele 6
BE - Belgio 5
EU - Europa 5
UA - Ucraina 5
CZ - Repubblica Ceca 3
HU - Ungheria 3
MA - Marocco 3
AR - Argentina 2
AZ - Azerbaigian 2
EC - Ecuador 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
FR - Francia 1
GE - Georgia 1
HN - Honduras 1
ID - Indonesia 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.797
Città #
Chandler 354
Dublin 214
Santa Clara 178
Singapore 148
Ashburn 84
Beijing 77
Dearborn 74
Nanjing 62
Shanghai 56
Izmir 54
Boardman 42
Princeton 42
Helsinki 34
Shenyang 32
Wilmington 26
Kunming 21
Abidjan 20
Hebei 20
Nanchang 20
Jiaxing 18
San Mateo 18
Los Angeles 16
Moscow 16
Changsha 13
Tianjin 12
Frankfurt am Main 10
Munich 10
Ann Arbor 9
Guangzhou 9
Kocaeli 9
Jinan 8
Hefei 7
Pune 7
Toronto 7
Augusta 6
Bremen 6
Fremont 6
Hangzhou 6
Hong Kong 6
Seattle 6
Timisoara 6
Brussels 5
Dallas 5
Draper 5
Edinburgh 5
Grafing 5
Norwalk 5
Andover 4
Leawood 4
London 4
New York 4
Parma 4
Taizhou 4
Wuhan 4
Budapest 3
Cambridge 3
Fuzhou 3
Ningbo 3
Ottawa 3
Phoenix 3
Porto Alegre 3
Rio de Janeiro 3
Shijiazhuang 3
The Dalles 3
Uberlândia 3
Zanjan 3
Ardabil 2
Baku 2
Belo Horizonte 2
Bishkek 2
Borås 2
Brasília 2
Brno 2
Castelnuovo Rangone 2
Chengdu 2
Islamabad 2
Jiangnong 2
Lanzhou 2
Legnaro 2
Milan 2
Monmouth Junction 2
Mumbai 2
Patos de Minas 2
Ribeirão Preto 2
Riga 2
Salvador 2
Stockholm 2
São Paulo 2
Taiyuan 2
Adana 1
Almaty 1
Almirante Tamandaré 1
Amarante 1
Ambrolauri 1
Amman 1
Amsterdam 1
Aracaju 1
Balneário Camboriú 1
Balzar 1
Bangalore 1
Totale 1.920
Nome #
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 91
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 87
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 85
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 85
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 85
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 83
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 82
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 82
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 80
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 79
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 77
P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) 76
The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people 75
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 72
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 72
P.02.10: Bismuth-Containing Quadruple Therapy in Patients Infected by Helicobacter Pylori: A First Real Life Italian Experience 71
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 71
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population 70
P.14.3 A NON-INVASIVE MONITORING OF THE FUNCTIONALITY OF GASTRIC MUCOSA (GASTROPANEL TEST) IN DYSPEPTIC PATIENTS: A PRELIMINARY STUDY 68
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS 66
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 66
The cure for Helicobacter pylori ((HP) infection with double or triple omeprazole-based therápies in the elderly: Effects on eradication rate, chronic gastritis and serum anti-HP antibodies and pepsinogens 66
P.04.3 SERUM PEPSINOGEN II LEVELS AND IGG ANTI HELICOBACTER PYLORI ANTIBODIES MAY REPRESENT A NON-INVASIVE METHOD FOR THE DIAGNOSIS AND MONITORING OF H PYLORI-RELATED GASTRITIS 65
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 64
P.02.15: The Role of Gastropanel in the Evaluation of the Appropriateness of Proton PUMP Inhibitor (PPI)-Therapy Prescription in a Primary Care Population 64
P.02.19: Prevalence of H. Pylori Infection, Chronic Atrophic Gastritis and Reflux Disease in a Primary Care Population of North-East Italy with Serum Biomarker Panel (Gastropanel®) 64
P.07.2: Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study 63
Prevalence of H. pylori resistance to antibiotics in North-East Italy: A multicentered study 62
P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients 62
Serum Pepsinogen II as a non-invasive marker for diagnosis of Helicobacter pylori infection: a prospective study in a cohort of dyspeptic patients 62
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 62
P.16.3 IMPROVEMENT OF APPROPRIATENESS AND REDUCTION OF WAITING LISTS CONCERNING UPPER GI ENDOSCOPY OUTPATIENTS: A SINGLE-CENTRE PROSPECTIVE STUDY 61
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 60
Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status 60
Role of proton pump inhibitors in the prevention of upper GI bleeding in elderly acute and chronic NSAID users 56
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly 55
P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS 54
P.17.5 UPPER GI BLEEDING: CLINICAL AND DEMOGRAPHIC FEATURES IN AN ENDOSCOPIC POPULATION STUDY OF NORTH-EAST ITALY 49
La terapia delle malattie acido-correlate nell'anziano 47
The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease 47
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 46
P.09.9 DIAGNOSTIC ACCURACY OF AGE AND ALARM SYMPTOMS FOR UPPER GI MALIGNANCY IN PATIENTS WITH DYSPEPSIA IN AN ENDOSCOPIC UNIT 38
null 10
Totale 2.840
Categoria #
all - tutte 12.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 0 0 0 0 23 0
2020/202152 0 0 6 0 1 1 0 1 6 9 28 0
2021/2022183 0 0 0 9 20 5 0 16 6 17 16 94
2022/2023924 72 114 68 93 58 122 1 84 273 3 32 4
2023/2024249 14 26 4 9 23 56 4 26 12 12 32 31
2024/2025830 36 52 66 35 139 139 37 46 176 95 9 0
Totale 2.840